TORLEY HELEN (PRESIDENT AND CEO) sold 2.3% of their position (16.57K shares) of HALOZYME THERAPEUTICS, INC. on the open market
Open‑market sale worth $1.14M — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
Common Stock
Shares
−25K
Price / share
—
Trade value
—
% of position
Common Stock
Shares
+16.57K
Price / share
$8.11
Trade value
$134.37K
% of position
Common Stock
Shares
−10.41K
Price / share
$68.51
Trade value
$712.94K
% of position
Common Stock
Shares
−5.40K
Price / share
$69.44
Trade value
$375.12K
% of position
Common Stock
Shares
−500.00
Price / share
$70.36
Trade value
$35.18K
% of position
Common Stock
Shares
−261.00
Price / share
$71.60
Trade value
$18.69K
% of position
Net shares
−25K
Net value
-$1.01M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/26/2025 | G · Gift | −25K | — | — | 3.4% | 733.72K | 708.72K |
| Common Stock Direct | 12/1/2025 | M · Option Exercise | +16.57K | $8.11 | $134.37K | 2.3% | 708.72K | 725.29K |
| Common Stock Direct | 12/1/2025 | S · Sale | −10.41K | $68.51 | $712.94K | 1.4% | 725.29K | 714.88K |
| Common Stock Direct | 12/1/2025 | S · Sale | −5.40K | $69.44 | $375.12K | 0.8% | 714.88K | 709.48K |
| Common Stock Direct | 12/1/2025 | S · Sale | −500.00 | $70.36 | $35.18K | 0.1% | 709.48K | 708.98K |
| Common Stock Direct | 12/1/2025 | S · Sale | −261.00 | $71.60 | $18.69K | 0.0% | 708.98K | 708.72K |
| Total | −25K | -$1.01M | ||||||
Option to Purchase Common Stock
Common Stock
16.57K shares
Shares
−16.57K
Strike price
8.11
Held after
0.00
Exercisable
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Option to Purchase Common Stock Direct | Common Stock16.57K shares | 12/1/2025 | M · Option Exercise | −16.57K | 8.11 | — | 0.00 |